Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHEERS: Expanded Cord Blood T Cells for Viral Infection
NCT03594981Phase 2Active, not recruiting
- Sponsor
- Catherine Bollard
- Start
- Jan 2018
- Primary completion
- Nov 2026
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of HLA-matched multivirus-specific cytotoxic T lymphocytes in viral infection, cytomegalovirus infection (CMV), Epstein-Barr virus infection, BK polyomavirus infection, adenovirus infection, sponsored by Catherine Bollard. Started Jan 2018; status: active, not recruiting.
02
Drugs
HLA-matched multivirus-specific cytotoxic T lymphocytes
03
Conditions
viral infectioncytomegalovirus infection (CMV)Epstein-Barr virus infectionBK polyomavirus infectionadenovirus infection
Beyond the preview
Go deeper on NCT03594981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03594981.